1. Home
  2. CBL vs FTRE Comparison

CBL vs FTRE Comparison

Compare CBL & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • FTRE
  • Stock Information
  • Founded
  • CBL 1978
  • FTRE 1996
  • Country
  • CBL United States
  • FTRE United States
  • Employees
  • CBL N/A
  • FTRE N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • FTRE Medical Specialities
  • Sector
  • CBL Real Estate
  • FTRE Health Care
  • Exchange
  • CBL Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • CBL 777.7M
  • FTRE 864.4M
  • IPO Year
  • CBL 1993
  • FTRE N/A
  • Fundamental
  • Price
  • CBL $29.23
  • FTRE $9.40
  • Analyst Decision
  • CBL
  • FTRE Hold
  • Analyst Count
  • CBL 0
  • FTRE 9
  • Target Price
  • CBL N/A
  • FTRE $12.06
  • AVG Volume (30 Days)
  • CBL 116.7K
  • FTRE 1.5M
  • Earning Date
  • CBL 11-10-2025
  • FTRE 11-07-2025
  • Dividend Yield
  • CBL 6.16%
  • FTRE N/A
  • EPS Growth
  • CBL 128.05
  • FTRE N/A
  • EPS
  • CBL 2.10
  • FTRE N/A
  • Revenue
  • CBL $539,452,000.00
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • CBL N/A
  • FTRE N/A
  • Revenue Next Year
  • CBL N/A
  • FTRE N/A
  • P/E Ratio
  • CBL $13.86
  • FTRE N/A
  • Revenue Growth
  • CBL 2.20
  • FTRE N/A
  • 52 Week Low
  • CBL $21.10
  • FTRE $3.97
  • 52 Week High
  • CBL $33.54
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • CBL 39.34
  • FTRE 53.01
  • Support Level
  • CBL $29.80
  • FTRE $9.25
  • Resistance Level
  • CBL $30.70
  • FTRE $9.89
  • Average True Range (ATR)
  • CBL 0.64
  • FTRE 0.57
  • MACD
  • CBL -0.22
  • FTRE -0.12
  • Stochastic Oscillator
  • CBL 6.46
  • FTRE 45.93

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: